Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Evolus Inc., 3 years.
Evolus Inc.
Director
Telix Pharmaceuticals Limited
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 17, 2026 | Evolus Inc. | Grant or award | +45,559 | — | — |
| Mar 7, 2025 | Evolus Inc. | Grant or award | +7,364 | — | — |
| May 14, 2024 | Evolus Inc. | Open-market sale | −6,718 | $12.60 | $84,647 |
| May 13, 2024 | Evolus Inc. | Open-market sale | −3,643 | $12.72 | $46,339 |
| Feb 7, 2024 | Evolus Inc. | Grant or award | +6,464 | — | — |
| Jan 27, 2023 | Evolus Inc. | Grant or award | +8,293 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.